NDC 58005-663 - GENTAMICIN PIGLET
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58005-663
- Package NDCs from labels
- 58005-663-04, 58005-663-05, 58005-663-06
- Manufacturer
- Sparhawk Laboratories, Inc.
- Effective date
- 2013-06-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gentamicin Piglet Injection (GENTAMICIN SULFATE, USP) Piglet Injection - 5 mg/mL | Sparhawk Laboratories, Inc. | 2013-06-10 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58005-663-04 | GENTAMICIN PIGLET | 100 mL in 1 VIAL | INJECTION | 100 | 3 | |
| 58005-663-05 | GENTAMICIN PIGLET | 250 mL in 1 VIAL | INJECTION | 250 | 3 | |
| 58005-663-06 | GENTAMICIN PIGLET | 500 mL in 1 VIAL | INJECTION | 500 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTAMICIN PIGLET (GENTAMICIN SULFATE) INJECTION [SPARHAWK LABORATORIES, INC.] | 3 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTAMICIN PIGLET (GENTAMICIN SULFATE) INJECTION [SPARHAWK LABORATORIES, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| gentamicin sulfate | GENTAMICIN SULFATE | DIRECT RX | 51a411a0-2671-4c1c-bf25-e29b32efed0c | 2024-01-10 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 2023-12-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 16474069-510b-0754-9d78-9bc0354f6549 | 2023-11-23 | Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 9e550dc9-509e-da05-8a97-ecbd0f5dd633 | 2023-11-22 | Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 0cce2238-28d3-4280-b520-ffc3067a2ffa | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | be5b414e-d598-4721-80ee-5836156ad210 | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | a73a5453-c091-43fd-aae2-d992152363b1 | 2023-10-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Hikma Pharmaceuticals USA Inc. | 51fffac8-fb6e-4f7f-b2de-440252781a42 | 2023-09-07 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | A-S Medication Solutions | 76fabcd6-4da3-49e3-85a1-ca4fac55a207 | 2023-05-08 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | a8b15217-cccb-2260-e053-2995a90a709d | 2023-05-03 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | 4cfbe37e-11d6-46fc-b287-0561387b17b7 | 2023-01-31 | Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate in Sodium Chloride | GENTAMICIN SULFATE | Baxter Healthcare Corporation | 449c9a41-d61e-49fd-b5e3-d76f74b92acf | 2023-01-26 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Asclemed USA, Inc. | b59e49e0-640b-43c3-ad07-711d1bb154e9 | 2022-07-19 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 3a6677a6-def5-443e-82bc-c185d41f03b7 | 2022-06-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Asclemed USA, Inc. | a54e5c95-609d-4d66-9573-5d1ac78fa58f | 2022-03-04 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | cf4386ba-c62a-4ee8-ab59-1bb2e737a5da | 2021-05-01 | Adverse reactions | 8X7386QRLV |
| Gentak | GENTAMICIN SULFATE | Proficient Rx LP | aebfe247-cdf7-4acb-97b3-6d4341d7c815 | 2019-11-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 2098faaa-7f60-4640-8c37-19456ebba653 | 2019-11-01 | Warnings, Adverse reactions | 8X7386QRLV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.